TradingMarkets is proud to present our new Stock Indicators. These indicators are based on our latest quantitative research into "How Markets Really Work". You will be able to quickly identify specific stocks that have historically made strong up moves (or down moves) over the next 1 to 5 days. All indicators have been backtested from 1/1/1995 to 6/30/2006. These powerful and versatile indicators can be combined with your current trading methodologies to form a watchlist of stocks prior to each day's open.
These new lists are updated every trading day by 9:30pm ET and are available to TradingMarkets members. Click here for a free trial.
Here is a screenshot of our New Stock Indicators:

Here are explanations and examples for some of the indicators above:

MedImmune (MEDI | Quote | Chart | News | PowerRating) appeared on our indicator list on February 8, 2007 and had gapped down 6.2% from the previous day's close. Note that MEDI was trading above its 200-day simple moving average (red line). Over the next 7 sessions, MEDI has gained 7.7%.


Multi-Fineline Electronix (MFLX | Quote | Chart | News | PowerRating) appeared on our Gaps Up 5% or More
List on February 8, 2007 after gapping up a whopping 12.6%. If MFLX had
been shorted after appearing on our February 8th indicator list, there would
have been a gain of 4.8% over the next 4 sessions.

To learn more on how to use our indicators in conjunction with our PowerRatings you can attend a free class, presented by market veteran Steve Primo. Topics covered include timing your entries and exits, daytrading with PowerRatings, and how to use PowerRatings with our new Preferred Stock List.
Darren Wong
Associate Editor
darrenw@tradingmarkets.com
Would you like to receive PowerRatings for full month for free? Send us your
PowerRatings strategy and if we accept it for publication, you will receive one
free month of unlimited access to PowerRatings. If you are already a monthly or
annual PowerRatings subscriber, you will receive an additional three months if
we publish your strategy.